Tower Research Capital (TRC)’s ECARX Holdings ECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.3K Buy
19,611
+16,678
+569% +$19K ﹤0.01% 3339
2026
Q1
$2.87K Buy
+2,933
New +$4.66K ﹤0.01% 4406
2025
Q3
– Sell
-34,544
Closed -$70.8K – 5305
2025
Q2
$70.8K Buy
+34,544
New +$49.9K ﹤0.01% 2673
2025
Q1
– Sell
-14,976
Closed -$31.6K – 5329
2024
Q4
$31.6K Buy
+14,976
New +$27.6K ﹤0.01% 2872
2024
Q3
– Sell
-2,154
Closed -$4.44K – 5768
2024
Q2
$4.44K Sell
2,154
-3,688
-63% -$5.59K ﹤0.01% 4784
2024
Q1
$11.4K Buy
5,842
+5,463
+1,441% +$13.3K ﹤0.01% 3563
2023
Q4
$1.2K Buy
+379
New +$1.24K ﹤0.01% 5416
2023
Q3
– Sell
-2,457
Closed -$17.1K – 6002
2023
Q2
$17.1K Sell
2,457
-292
-11% -$1.84K ﹤0.01% 3523
2023
Q1
$16K Buy
2,749
+1,362
+98% +$7.96K ﹤0.01% 3684
2022
Q4
$11K Buy
+1,387
New +$11.6K ﹤0.01% 3807

Other funds holding ECX

Tower Research Capital (TRC)'s ECX Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its ECARX Holdings (ECX) stake by 569% in Q2 2026, buying an estimated $19K and bringing the position to 19,611 shares worth $25.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3339.

Tower Research Capital (TRC) first reported a position in ECX in Q4 2022 and has held it in 10 quarters since. The position peaked at $70.8K in Q2 2025. 39 funds tracked by Wall St. Rank hold ECX as of Q2 2026.

  • Tower Research Capital (TRC) held 19,611 shares of ECARX Holdings worth $25.3K as of Q2 2026.
  • Tower Research Capital (TRC) bought 16,678 ECARX Holdings shares in Q2 2026, an estimated $19K.
  • ECARX Holdings made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3339 holding.
  • Tower Research Capital (TRC) first reported a position in ECARX Holdings in Q4 2022 and has held it in 10 quarters since.
  • Tower Research Capital (TRC)'s ECARX Holdings position peaked at $70.8K in Q2 2025.
  • 39 funds tracked by Wall St. Rank held ECARX Holdings as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.